GB1574246A - Prostaglandin derivatives and process for preparing the same - Google Patents

Prostaglandin derivatives and process for preparing the same Download PDF

Info

Publication number
GB1574246A
GB1574246A GB12991/77A GB1299177A GB1574246A GB 1574246 A GB1574246 A GB 1574246A GB 12991/77 A GB12991/77 A GB 12991/77A GB 1299177 A GB1299177 A GB 1299177A GB 1574246 A GB1574246 A GB 1574246A
Authority
GB
United Kingdom
Prior art keywords
methyl
ethyl
pyrrolidinone
prostaglandin
mixture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB12991/77A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Labaz SA
Original Assignee
Labaz SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Labaz SA filed Critical Labaz SA
Publication of GB1574246A publication Critical patent/GB1574246A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C53/00—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen
    • C07C53/126—Acids containing more than four carbon atoms
    • C07C53/128—Acids containing more than four carbon atoms the carboxylic group being bound to a carbon atom bound to at least two other carbon atoms, e.g. neo-acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4006—Esters of acyclic acids which can have further substituents on alkyl

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrrole Compounds (AREA)
GB12991/77A 1976-03-31 1977-03-28 Prostaglandin derivatives and process for preparing the same Expired GB1574246A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL49325A IL49325A (en) 1976-03-31 1976-03-31 8-aza-11-deoxy-pge1 derivatives,their preparation and pharmaceutical compositions containing them

Publications (1)

Publication Number Publication Date
GB1574246A true GB1574246A (en) 1980-09-03

Family

ID=11048789

Family Applications (1)

Application Number Title Priority Date Filing Date
GB12991/77A Expired GB1574246A (en) 1976-03-31 1977-03-28 Prostaglandin derivatives and process for preparing the same

Country Status (18)

Country Link
US (1) US4115401A (cg-RX-API-DMAC7.html)
JP (1) JPS52142060A (cg-RX-API-DMAC7.html)
BE (1) BE852941A (cg-RX-API-DMAC7.html)
CA (1) CA1074804A (cg-RX-API-DMAC7.html)
CH (2) CH624101A5 (cg-RX-API-DMAC7.html)
DD (1) DD130352A5 (cg-RX-API-DMAC7.html)
DE (1) DE2714129A1 (cg-RX-API-DMAC7.html)
ES (1) ES457385A1 (cg-RX-API-DMAC7.html)
FR (1) FR2346332A1 (cg-RX-API-DMAC7.html)
GB (1) GB1574246A (cg-RX-API-DMAC7.html)
HU (1) HU178040B (cg-RX-API-DMAC7.html)
IL (1) IL49325A (cg-RX-API-DMAC7.html)
IT (1) IT1075373B (cg-RX-API-DMAC7.html)
NL (1) NL7703503A (cg-RX-API-DMAC7.html)
NO (1) NO149428C (cg-RX-API-DMAC7.html)
PL (3) PL107544B1 (cg-RX-API-DMAC7.html)
SE (1) SE417603B (cg-RX-API-DMAC7.html)
SU (3) SU676162A3 (cg-RX-API-DMAC7.html)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7906017L (sv) * 1978-07-11 1980-02-13 Glaxo Group Ltd Prostanoida foreningar
US4320136A (en) * 1980-08-11 1982-03-16 E. I. Du Pont De Nemours And Company 8-Aza-16,16-difluoroprostanoids
US4456613A (en) * 1982-12-27 1984-06-26 E. I. Du Pont De Nemours And Company 6-Keto- and 6-hydroxy-8-azaprostanoids and anti-ulcer use thereof
US4530933A (en) * 1982-12-27 1985-07-23 E. I. Du Pont De Nemours And Company 8-Aza-13-thiaprostanoids and a method of use thereof as anti-ulcer agents
AP2002002555A0 (en) 1999-12-22 2002-06-30 Pfizer Prod Inc EP4 Receptor selective agonists in the treatment of osteoporosis.
EA200300379A1 (ru) 2000-11-27 2003-08-28 Пфайзер Продактс Инк. Селективные агонисты рецептора ep4 в лечении остеопороза
PL215425B1 (pl) * 2001-07-16 2013-12-31 Ono Pharmaceutical Co Pochodna pirolidonu, srodek farmaceutyczny zawierajacy te pochodna i jej zastosowanie
JP2004521954A (ja) 2001-07-16 2004-07-22 エフ．ホフマン−ラ　ロシュ　アーゲー Ｅｐ４受容体作用薬としてのプロスタグランジン類似体
JP4273407B2 (ja) * 2001-07-23 2009-06-03 小野薬品工業株式会社 Ｅｐ４アゴニストを有効成分とする骨量低下疾患の治療剤
AU2003211574A1 (en) 2002-03-05 2003-09-16 Ono Pharmaceutical Co., Ltd. 8-azaprostaglandin derivative compounds and drugs containing the compounds as the active ingredient
EP1490055A1 (en) * 2002-03-18 2004-12-29 Pfizer Products Inc. Use of selective ep4 receptor agonists for the treatment of liver failure, loss of patency of the ductus arteriosus, glaucoma or ocular hypertension
CA2511255C (en) * 2003-01-10 2009-04-07 F. Hoffmann-La Roche Ag 2-piperidone derivatives as prostaglandin agonists
US7179820B2 (en) 2003-06-06 2007-02-20 Allergan, Inc. Piperidinyl prostaglandin E analogs
US20080058375A1 (en) * 2004-01-08 2008-03-06 Elworthy Todd R 2-Piperidone derivatives as prostaglandin antagonists

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3975399A (en) * 1974-08-06 1976-08-17 E. I. Du Pont De Nemours And Company 1,5-Disubstituted-2-pyrrolidinones, -3-pyrrolin-2-ones, and -4-pyrrolin-2-ones

Also Published As

Publication number Publication date
FR2346332A1 (fr) 1977-10-28
DE2714129A1 (de) 1977-10-13
NO149428C (no) 1984-04-18
BE852941A (fr) 1977-09-28
IL49325A (en) 1979-11-30
PL197005A1 (pl) 1978-10-09
ES457385A1 (es) 1978-02-01
NL7703503A (nl) 1977-10-04
HU178040B (en) 1982-02-28
SE7703698L (sv) 1977-10-01
JPS52142060A (en) 1977-11-26
SE417603B (sv) 1981-03-30
SU715019A3 (ru) 1980-02-05
SU676162A3 (ru) 1979-07-25
NO771134L (no) 1977-10-03
IT1075373B (it) 1985-04-22
US4115401A (en) 1978-09-19
PL107643B1 (pl) 1980-02-29
SU837321A3 (ru) 1981-06-07
CH624101A5 (cg-RX-API-DMAC7.html) 1981-07-15
DD130352A5 (de) 1978-03-22
CA1074804A (en) 1980-04-01
CH628032A5 (fr) 1982-02-15
PL108289B1 (pl) 1980-03-31
PL107544B1 (pl) 1980-02-29
FR2346332B1 (cg-RX-API-DMAC7.html) 1980-05-09
IL49325A0 (en) 1976-05-31
NO149428B (no) 1984-01-09

Similar Documents

Publication Publication Date Title
EP0011928B1 (en) 3,5-dihydroxypentanoic ester derivatives having antihyperlipaemic activity, their manufacture and pharmaceutical compositions containing them
EP0059158B1 (de) Azaprostacycline, Verfahren zu ihrer Herstellung und ihre pharmazeutische Verwendung
CA1264320A (en) Prostaglandin analogues, process for their preparation and pharmaceutical compositions containing them
US4115401A (en) Prostaglandin derivatives and process for preparing the same
US4229466A (en) Sesquiterpene derivatives having anti-complementary activity
US4436934A (en) Bicyclic prostaglandin analogs and method of synthesis
WO1995010266A1 (fr) Inhibiteur de synthese de monoxyde d'azote
WO1983004021A1 (en) 2,3,4-trinor-1,5-inter-m-phenylene-prostacycline-i2 analogues, process for the preparation thereof and pharmaceutical compositions containing the same
US4351949A (en) Bicyclic prostaglandin analogs and method of synthesis
US3966745A (en) Vinvamine series cycloalkyl-alkyl esters
US4262008A (en) 2,4-Disubstituted 5-oxo-5H-hexahydrofuro[3,2b]pyrroles
US4024181A (en) Analogues of prostanoic acids
CA1076587A (en) Prostaglandin derivatives and process for preparing the same
EP0004335A2 (de) Neue Analoga von Prostacyclin, Verfahren und Zwischenprodukte zu ihrer Herstellung und ihre Verwendung als Arzneimittel
EP0013955A1 (de) Neue Analoga von Prostacyclin, deren Zwischenprodukte, Verfahren zu ihrer Herstellung sowie sie enthaltende Arzneimittel
DE2715921A1 (de) Neue zwischenprodukte und verfahren zur herstellung von thromboxan b tief 2
IE43689B1 (en) 2-(w-haloalkenyl)-cyclopentane-1-heptanoic acids,methods for preparation thereof and their use
DE1941933C3 (de) Basisch substituierte 10,11- Dihydro-5,10-endoxa-SH-dibenzo- [a,d] -cycloheptene und deren pharmakologisch verträgliche Säureadditionssalze, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
CH656120A5 (de) In 15-stellung einen cycloaliphatischen rest tragende derivate von 13,14-didehydrocarboprostacyclinen und verfahren zur herstellung derselben.
US3769316A (en) Prostaglandin intermediates
JPH0222071B2 (cg-RX-API-DMAC7.html)
JPS6032763A (ja) 新規な１１−オキソプロスタン酸誘導体ならびにその利用
NO812720L (no) Fremgangsmaate for fremstilling av heteroprostaglandinderivater
IE41407B1 (en) Analogues of prostanoic acids and process for preparing them
US3978081A (en) 11H,12H-[1]benzopyrano[2,3-b][1]benzopyran-11,12-dione and derivatives

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee